Oppenheimer Maintains Attractive Outlook And Price Target On China Biotech ... - Benzinga PDF Print
Benzinga"We continue to like the 3SBio story for its distant leadership position in the nephrology/cancer supportive care markets. We believe the promising prospect

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.